Patient P-03152
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
20%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S17
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+7
- Inflammatory activity+7
- Treatment adherence-4
- Toxicity-4
- Nutritional resilience-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log6.4/10
improving · +0.8 vs previous 14 d
Stress level
Daily log3.8/10
improving · -0.4 vs previous 14 d
Pessimism score
Daily log2.5/10
stable · -0.0 vs previous 14 d
Sleep quality
Wearable40.3/100
improving · +3.0 vs previous 14 d
Libido
Daily log4.6/10
improving · +0.4 vs previous 14 d
HRV
Wearable46.3 ms
improving · +4.1 vs previous 14 d
Toxicity
Blood21.8/100
improving · -8.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 104 from the failing basin, 21 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +6.8
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -3.8 next day
Main detractors to watch
- Poor metabolizerhidden · steering -12.7
- Bacteroides fragilis elevatedhidden · steering -7.4
- IL6 high-expression varianthidden · steering -7.3
- Alcoholperturbation · steering -7.1
- Alcoholdetractor · GI +4.3 next day
- Lactosedetractor · GI +3.1 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+4.3detractor · 95%
- Protein-3.8supporter · 95%
- Lactose+3.1detractor · 95%
- Caffeine+2.4detractor · 78%
- Dietary fat load+0.8no signal · 21%
- Histamine load+0.8no signal · 22%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- Mucosal barrier integrity ↓40
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 5.9 h, below personal baseline
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Autonomic recovery ↑20
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Poor metabolizerHigher exposure at standard dose
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4 · butyrate capacity 69/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 46 ms
- Sleep
- 6.3 h
- Steps
- 10,322
- Resting HR
- 58 bpm
Daily log: GI score 11, nutritional resilience 69, adherence 87.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.